226 related articles for article (PubMed ID: 27915266)
1. Systematic ajmaline challenge in patients with long QT 3 syndrome caused by the most common mutation: a multicentre study.
Hohmann S; Rudic B; Konrad T; Duncker D; König T; Tülümen E; Rostock T; Borggrefe M; Veltmann C
Europace; 2017 Oct; 19(10):1723-1729. PubMed ID: 27915266
[TBL] [Abstract][Full Text] [Related]
2. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
[TBL] [Abstract][Full Text] [Related]
3. Long-term flecainide therapy in type 3 long QT syndrome.
Chorin E; Taub R; Medina A; Flint N; Viskin S; Benhorin J
Europace; 2018 Feb; 20(2):370-376. PubMed ID: 28339995
[TBL] [Abstract][Full Text] [Related]
4. Pilsicainide Administration Unmasks a Phenotype of Brugada Syndrome in a Patient with Overlap Syndrome due to the E1784K SCN5A Mutation.
Hasebe H; Yokoya T; Murakoshi N; Kurebayashi N
Intern Med; 2020 Jan; 59(1):83-87. PubMed ID: 31484910
[TBL] [Abstract][Full Text] [Related]
5. Dual phenotypic transmission in Brugada syndrome.
Hermida JS; Arnalsteen-Dassonvalle E; Kubala M; Mathiron A; Traulle S; Anbazhagan K; Hermida A; Rochette J
Arch Cardiovasc Dis; 2013; 106(6-7):366-72. PubMed ID: 23810369
[TBL] [Abstract][Full Text] [Related]
6. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome.
Makita N; Behr E; Shimizu W; Horie M; Sunami A; Crotti L; Schulze-Bahr E; Fukuhara S; Mochizuki N; Makiyama T; Itoh H; Christiansen M; McKeown P; Miyamoto K; Kamakura S; Tsutsui H; Schwartz PJ; George AL; Roden DM
J Clin Invest; 2008 Jun; 118(6):2219-29. PubMed ID: 18451998
[TBL] [Abstract][Full Text] [Related]
7. Lidocaine attenuation testing: An in vivo investigation of putative LQT3-associated variants in the SCN5A-encoded sodium channel.
Anderson HN; Bos JM; Kapplinger JD; Meskill JM; Ye D; Ackerman MJ
Heart Rhythm; 2017 Aug; 14(8):1173-1179. PubMed ID: 28412158
[TBL] [Abstract][Full Text] [Related]
8. Value of the sodium-channel blocker challenge in Brugada syndrome.
Therasse D; Sacher F; Babuty D; Mabo P; Mansourati J; Kyndt F; Redon R; Schott JJ; Barc J; Probst V; Gourraud JB
Int J Cardiol; 2017 Oct; 245():178-180. PubMed ID: 28784436
[TBL] [Abstract][Full Text] [Related]
9. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
[TBL] [Abstract][Full Text] [Related]
10. Flecainide provocation reveals concealed brugada syndrome in a long QT syndrome family with a novel L1786Q mutation in SCN5A.
Kanters JK; Yuan L; Hedley PL; Stoevring B; Jons C; Bloch Thomsen PE; Grunnet M; Christiansen M; Jespersen T
Circ J; 2014; 78(5):1136-43. PubMed ID: 24599044
[TBL] [Abstract][Full Text] [Related]
11. Yield and Pitfalls of Ajmaline Testing in the Evaluation of Unexplained Cardiac Arrest and Sudden Unexplained Death: Single-Center Experience With 482 Families.
Tadros R; Nannenberg EA; Lieve KV; Škorić-Milosavljević D; Lahrouchi N; Lekanne Deprez RH; Vendrik J; Reckman YJ; Postema PG; Amin AS; Bezzina CR; Wilde AAM; Tan HL
JACC Clin Electrophysiol; 2017 Dec; 3(12):1400-1408. PubMed ID: 29759671
[TBL] [Abstract][Full Text] [Related]
12. Differential calcium sensitivity in Na
Abdelsayed M; Baruteau AE; Gibbs K; Sanatani S; Krahn AD; Probst V; Ruben PC
J Physiol; 2017 Sep; 595(18):6165-6186. PubMed ID: 28734073
[TBL] [Abstract][Full Text] [Related]
13. Ventricular arrhythmia during ajmaline challenge for the Brugada syndrome.
Dobbels B; De Cleen D; Ector J
Europace; 2016 Oct; 18(10):1501-1506. PubMed ID: 26941343
[TBL] [Abstract][Full Text] [Related]
14. Malignant response to ajmaline challenge in SCN5A mutation carriers: experience from a large familial study.
Gandjbakhch E; Fressart V; Duthoit G; Marquié C; Deharo JC; Pousset F; Hebert JL; Simon F; Himbert C; Klug D; Charron P; Hidden-Lucet F
Int J Cardiol; 2014 Mar; 172(1):256-8. PubMed ID: 24476701
[No Abstract] [Full Text] [Related]
15. High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia.
Hasdemir C; Payzin S; Kocabas U; Sahin H; Yildirim N; Alp A; Aydin M; Pfeiffer R; Burashnikov E; Wu Y; Antzelevitch C
Heart Rhythm; 2015 Jul; 12(7):1584-94. PubMed ID: 25998140
[TBL] [Abstract][Full Text] [Related]
16. The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge.
Priori SG; Napolitano C; Schwartz PJ; Bloise R; Crotti L; Ronchetti E
Circulation; 2000 Aug; 102(9):945-7. PubMed ID: 10961955
[TBL] [Abstract][Full Text] [Related]
17. Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data.
Chorin E; Hu D; Antzelevitch C; Hochstadt A; Belardinelli L; Zeltser D; Barajas-Martinez H; Rozovski U; Rosso R; Adler A; Benhorin J; Viskin S
Circ Arrhythm Electrophysiol; 2016 Oct; 9(10):. PubMed ID: 27733495
[TBL] [Abstract][Full Text] [Related]
18. Anti-arrhythmic potential of the late sodium current inhibitor GS-458967 in murine Scn5a-1798insD+/- and human SCN5A-1795insD+/- iPSC-derived cardiomyocytes.
Portero V; Casini S; Hoekstra M; Verkerk AO; Mengarelli I; Belardinelli L; Rajamani S; Wilde AAM; Bezzina CR; Veldkamp MW; Remme CA
Cardiovasc Res; 2017 Jun; 113(7):829-838. PubMed ID: 28430892
[TBL] [Abstract][Full Text] [Related]
19. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation.
Windle JR; Geletka RC; Moss AJ; Zareba W; Atkins DL
Ann Noninvasive Electrocardiol; 2001 Apr; 6(2):153-8. PubMed ID: 11333173
[TBL] [Abstract][Full Text] [Related]
20. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters.
Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T
Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
